相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Renal Cell Carcinoma With Chromosome 6p Amplification Including the TFEB Gene A Novel Mechanism of Tumor Pathogenesis?
Sean R. Williamson et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
TFEB-amplified Renal Cell Carcinomas An Aggressive Molecular Subset Demonstrating Variable Melanocytic Marker Expression and Morphologic Heterogeneity
Pedram Argani et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
W. Marston Linehan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The DEK oncoprotein is upregulated by multiple leukemia-associated fusion genes
Carl Sanden et al.
BLOOD CELLS MOLECULES AND DISEASES (2015)
Outcome prediction for patients with renal cell carcinoma
Christine M. Lohse et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2015)
FOXP4 modulates tumor growth and independently associates with miR-138 in non-small cell lung cancer cells
Tian Yang et al.
TUMOR BIOLOGY (2015)
Spectrum of diverse genomic alterations define non-clear cell renal carcinoma
Steffen Durinck et al.
NATURE GENETICS (2015)
The human oncoprotein and chromatin architectural factor DEK counteracts DNA replication stress
A. Deutzmann et al.
ONCOGENE (2015)
The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancers
L. M. Privette Vinnedge et al.
ONCOGENE (2015)
The RUNX family: developmental regulators in cancer
Yoshiaki Ito et al.
NATURE REVIEWS CANCER (2015)
Aggressive and nonaggressive translocation t(6;11) renal cell carcinoma: comparative study of 6 cases and review of the literature
Kvetoslava Peckova et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2014)
BIMA V3: an aligner customized for mate pair library sequencing
Travis M. Drucker et al.
BIOINFORMATICS (2014)
DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer
Javier Martinez-Useros et al.
BMC CANCER (2014)
Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases
Jennelle C. Hodge et al.
MODERN PATHOLOGY (2014)
TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling
Lingyi Fu et al.
MOLECULAR CANCER (2014)
The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation
Carl Sanden et al.
MOLECULAR CANCER (2014)
Human and Mouse VEGFA-Amplified Hepatocellular Carcinomas Are Highly Sensitive to Sorafenib Treatment
Elad Horwitz et al.
CANCER DISCOVERY (2014)
DEK over expression as an independent biomarker for poor prognosis in colorectal cancer
Lijuan Lin et al.
BMC CANCER (2013)
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Forkhead box proteins: tuning forks for transcriptional harmony
Eric W. -F. Lam et al.
NATURE REVIEWS CANCER (2013)
Gene Fusions Associated with Recurrent Amplicons Represent a Class of Passenger Aberrations in Breast Cancer
Shanker Kalyana-Sundaram et al.
NEOPLASIA (2012)
Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer
Antara Datta et al.
BMC CANCER (2011)
Genetic Amplification of the Vascular Endothelial Growth Factor (VEGF) Pathway Genes, Including VEGFA, in Human Osteosarcoma
Jilong Yang et al.
CANCER (2011)
Molecular basis for the actions of Hsp90 inhibitors and cancer therapy
Hiroshi Yamaki et al.
JOURNAL OF ANTIBIOTICS (2011)
The human DEK oncogene stimulates β-catenin signaling, invasion and mammosphere formation in breast cancer
L. M. Privette Vinnedge et al.
ONCOGENE (2011)
Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy
Bekim Sadikovic et al.
BMC CANCER (2010)
Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions
J. Akech et al.
ONCOGENE (2010)
Overexpression of the Cellular DEK Protein Promotes Epithelial Transformation In vitro and In vivo
Trisha M. Wise-Draper et al.
CANCER RESEARCH (2009)
Melanoma Proliferation and Chemoresistance Controlled by the DEK Oncogene
Michael S. Khodadoust et al.
CANCER RESEARCH (2009)
Immunoreactivity of p27(Kip1), cyclin D3, and Ki67 in conventional renal cell carcinoma
Ambrosi Pertia et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2009)
Clinicopathological significance of DEK overexpression in serous ovarian tumors
Songying Han et al.
PATHOLOGY INTERNATIONAL (2009)
Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells
Jitesh Pratap et al.
CANCER RESEARCH (2008)
DEK overexpression in uterine cervical cancers
Qunying Wu et al.
PATHOLOGY INTERNATIONAL (2008)
Array painting reveals a high frequency of balanced translocations in breast cancer cell lines that break in cancer-relevant genes
K. D. Howarth et al.
ONCOGENE (2008)
Novel 6p rearrangements and recurrent translocation breakpoints in retinoblastoma cell lines identified by spectral karyotyping and mBAND analyses
Jan. A. Paderova et al.
CANCER GENETICS AND CYTOGENETICS (2007)
Identification of differentially expressed genes in tobacco chewing-mediated oral cancer by differential display-polymerase chain reaction
J. K. Nagpal et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
DEK expression is controlled by E2F and deregulated in diverse tumor types
Maria Stella Carro et al.
CELL CYCLE (2006)
Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases
C Langner et al.
MODERN PATHOLOGY (2004)
Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma
CC Lau et al.
GENES CHROMOSOMES & CANCER (2004)
Armadillo repeat proteins: beyond the animal kingdom
JC Coates
TRENDS IN CELL BIOLOGY (2003)
Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation
IJ Davis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cyclin D3 protein content in human renal cell carcinoma in relation to cyclin D1 and clinico-pathological parameters
Y Hedberg et al.
ACTA ONCOLOGICA (2002)
The identification of novel therapeutic targets for the treatment of malignant brain tumors
RA Kroes et al.
CANCER LETTERS (2000)
分享论文
